Rating Change
JP Morgan reiterated its Overweight rating on Insmed Incorporated (NASDAQ:INSM) on August 10, 2026.
reiterateNASDAQ:INSM
JP Morgan Reiterates Overweight Rating on Insmed Incorporated (INSM)
JP Morgan reiterated its Overweight rating on Insmed Incorporated (NASDAQ:INSM) on August 10, 2026.
At publication ·
What changed
Insmed Incorporated (NASDAQ:INSM) · reiterate
- Firm
- JP Morgan
- Rating
- Overweight to Overweight
- Price at event
- $134.75
- Market capitalization
- $41.6B
At a glance
Key takeaways
- JP Morgan reiterated an Overweight rating on Insmed Incorporated (NASDAQ:INSM) on August 10, 2026, with the stock trading at $134.75 and a market capitalization of $41.6 billion.
Market Context
Insmed Incorporated operates in the Healthcare sector. The stock currently trades at $134.75 with a market capitalization of $41.6B. The stock has gained 17.8% over the past 52 weeks.
Analyst coverage from JP Morgan provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Insmed Incorporated.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Insmed Incorporated
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 10, 2026 | Truist Securities | Buy | N/A |
| Aug 10, 2026 | JP Morgan | Overweight | N/A |
| Aug 07, 2026 | Evercore ISI Group | Outperform | N/A |
| Aug 07, 2026 | Guggenheim | Buy | N/A |
| Aug 07, 2026 | Wells Fargo | Overweight | N/A |
Related Tools: Analyst Ratings Dashboard | View INSM Stock Page
Frequently Asked Questions
What does the Overweight rating mean for INSM?
A rating of Overweight from JP Morgan reflects the analyst's outlook on Insmed Incorporated (NASDAQ:INSM). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the INSM forecast page.